|
1.
|
Kouzarides T: Chromatin modifications and
their function. Cell. 128:693–705. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Cloos PA, Christensen J, Agger K and Helin
K: Erasing the methyl mark: histone demethylases at the center of
cellular differentiation and disease. Genes Dev. 22:1115–1140.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Chi P, Allis CD and Wang GG: Covalent
histone modifications--miswritten, misinterpreted and mis-erased in
human cancers. Nat Rev Cancer. 10:457–469. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Kooistra SM and Helin K: Molecular
mechanisms and potential functions of histone demethylases. Nat Rev
Mol Cell Biol. 13:297–311. 2012.PubMed/NCBI
|
|
5.
|
Klose RJ and Zhang Y: Regulation of
histone methylation by demethylimination and demethylation. Nat Rev
Mol Cell Biol. 8:307–318. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Yap KL and Zhou MM: Keeping it in the
family: diverse histone recognition by conserved structural folds.
Crit Rev Biochem Mol Biol. 45:488–505. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Whetstine JR, Nottke A, Lan F, Huarte M,
Smolikov S, Chen Z, Spooner E, Li E, Zhang G, Colaiacovo M and Shi
Y: Reversal of histone lysine trimethylation by the JMJD2 family of
histone demethylases. Cell. 125:467–481. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Cloos PA, Christensen J, Agger K, Maiolica
A, Rappsilber J, Antal T, Hansen KH and Helin K: The putative
oncogene GASC1 demethylates tri- and dimethylated lysine 9 on
histone H3. Nature. 442:307–311. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Klose RJ, Yamane K, Bae Y, Zhang D,
Erdjument-Bromage H, Tempst P, Wong J and Zhang Y: The
transcriptional repressor JHDM3A demethylates trimethyl histone H3
lysine 9 and lysine 36. Nature. 442:312–316. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Fodor BD, Kubicek S, Yonezawa M,
O’Sullivan RJ, Sengupta R, Perez-Burgos L, Opravil S, Mechtler K,
Schotta G and Jenuwein T: Jmjd2b antagonizes H3K9 trimethylation at
pericentric heterochromatin in mammalian cells. Genes Dev.
20:1557–1562. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Shin S and Janknecht R: Diversity within
the JMJD2 histone demethylase family. Biochem Biophys Res Commun.
353:973–977. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Trojer P, Zhang J, Yonezawa M, Schmidt A,
Zheng H, Jenuwein T and Reinberg D: Dynamic histone H1 isotype 4
methylation and demethylation by histone lysine methyltransferase
G9a/KMT1C and the Jumonji domain-containing JMJD2/KDM4 proteins. J
Biol Chem. 284:8395–8405. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Weiss T, Hergeth S, Zeissler U, Izzo A,
Tropberger P, Zee BM, Dundr M, Garcia BA, Daujat S and Schneider R:
Histone H1 variant-specific lysine methylation by G9a/KMT1C and
Glp1/ KMT1D. Epigenetics Chromatin. 3:72010. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Yang J, Jubb AM, Pike L, Buffa FM, Turley
H, Baban D, Leek R, Gatter KC, Ragoussis J and Harris AL: The
histone demethylase JMJD2B is regulated by estrogen receptor alpha
and hypoxia, and is a key mediator of estrogen induced growth.
Cancer Res. 70:6456–6466. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Kawazu M, Saso K, Tong KI, McQuire T, Goto
K, Son DO, Wakeham A, Miyagishi M, Mak TW and Okada H: Histone
demethylase JMJD2B functions as a co-factor of estrogen receptor in
breast cancer proliferation and mammary gland development. PLoS
One. 6:e178302011. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Shi L, Sun L, Li Q, Liang J, Yu W, Yi X,
Yang X, Li Y, Han X, Zhang Y, Xuan C, Yao Z and Shang Y: Histone
demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes
hormonally responsive breast carcinogenesis. Proc Natl Acad Sci
USA. 108:7541–7546. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Northcott PA, Nakahara Y, Wu X, Feuk L,
Ellison DW, Croul S, Mack S, Kongkham PN, Peacock J, Dubuc A, Ra
YS, Zilberberg K, McLeod J, Scherer SW, Sunil Rao J, Eberhart CG,
Grajkowska W, Gillespie Y, Lach B, Grundy R, Pollack IF, Hamilton
RL, van Meter T, Carlotti CG, Boop F, Bigner D, Gilbertson RJ,
Rutka JT and Taylor MD: Multiple recurrent genetic events converge
on control of histone lysine methylation in medulloblastoma. Nat
Genet. 41:465–472. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Mooney SM, Grande JP, Salisbury JL and
Janknecht R: Sumoylation of p68 and p72 RNA helicases affects
protein stability and transactivation potential. Biochemistry.
49:1–10. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Mooney SM, Goel A, D’Assoro AB, Salisbury
JL and Janknecht R: Pleiotropic effects of p300-mediated
acetylation on p68 and p72 RNA helicase. J Biol Chem.
285:30443–30452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Shin S and Janknecht R: Concerted
activation of the Mdm2 promoter by p72 RNA helicase and the
coactivators p300 and P/CAF. J Cell Biochem. 101:1252–1265. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Knebel J, De Haro L and Janknecht R:
Repression of transcription by TSGA/Jmjd1a, a novel interaction
partner of the ETS protein ER71. J Cell Biochem. 99:319–329. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Papoutsopoulou S and Janknecht R:
Phosphorylation of ETS transcription factor ER81 in a complex with
its coactivators CREB-binding protein and p300. Mol Cell Biol.
20:7300–7310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Kim TD, Shin S and Janknecht R: Repression
of Smad3 activity by histone demethylase SMCX/JARID1C. Biochem
Biophys Res Commun. 366:563–567. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Dowdy SC, Mariani A and Janknecht R:
HER2/Neu- and TAK1-mediated up-regulation of the transforming
growth factor beta inhibitor Smad7 via the ETS protein ER81. J Biol
Chem. 278:44377–44384. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
De Haro L and Janknecht R: Cloning of the
murine ER71 gene (Etsrp71) and initial characterization of its
promoter. Genomics. 85:493–502. 2005.PubMed/NCBI
|
|
26.
|
Wu J and Janknecht R: Regulation of the
ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1
and protein kinase A. J Biol Chem. 277:42669–42679. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Goel A and Janknecht R:
Acetylation-mediated transcriptional activation of the ETS protein
ER81 by p300, P/CAF, and HER2/ Neu. Mol Cell Biol. 23:6243–6254.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Shin S, Rossow KL, Grande JP and Janknecht
R: Involvement of RNA helicases p68 and p72 in colon cancer. Cancer
Res. 67:7572–7578. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Kim J, Shin S, Subramaniam M, Bruinsma E,
Kim TD, Hawse JR, Spelsberg TC and Janknecht R: Histone demethylase
JARID1B/ KDM5B is a corepressor of TIEG1/KLF10. Biochem Biophys Res
Commun. 401:412–416. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Kim TD, Oh S, Shin S and Janknecht R:
Regulation of tumor suppressor p53 and HCT116 cell physiology by
histone demethylase JMJD2D/KDM4D. PLoS One. 7:e346182012.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Shin S, Kim TD, Jin F, van Deursen JM,
Dehm SM, Tindall DJ, Grande JP, Munz JM, Vasmatzis G and Janknecht
R: Induction of prostatic intraepithelial neoplasia and modulation
of androgen receptor by ETS variant 1/ETS-related protein 81.
Cancer Res. 69:8102–8110. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Normanno N, Di Maio M, De Maio E, De Luca
A, de Matteis A, Giordano A and Perrone F: Mechanisms of endocrine
resistance and novel therapeutic strategies in breast cancer.
Endocr Relat Cancer. 12:721–747. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Paech K, Webb P, Kuiper GG, Nilsson S,
Gustafsson J, Kushner PJ and Scanlan TS: Differential ligand
activation of estrogen receptors ERalpha and ERbeta at AP1 sites.
Science. 277:1508–1510. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Carroll JS and Brown M: Estrogen receptor
target gene: an evolving concept. Mol Endocrinol. 20:1707–1714.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Shaulian E and Karin M: AP-1 as a
regulator of cell life and death. Nat Cell Biol. 4:E131–E136. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Mallette FA, Mattiroli F, Cui G, Young LC,
Hendzel MJ, Mer G, Sixma TK and Richard S: RNF8- and
RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1
recruitment to DNA damage sites. EMBO J. 31:1865–1878. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Li BX, Zhang MC, Luo CL, Yang P, Li H, Xu
HM, Xu HF, Shen YW, Xue AM and Zhao ZQ: Effects of RNA
interference-mediated gene silencing of JMJD2A on human breast
cancer cell line MDA-MB-231 in vitro. J Exp Clin Cancer Res.
30:902011. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Liu G, Bollig-Fischer A, Kreike B, van de
Vijver MJ, Abrams J, Ethier SP and Yang ZQ: Genomic amplification
and oncogenic properties of the GASC1 histone demethylase gene in
breast cancer. Oncogene. 28:4491–4500. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Altucci L, Addeo R, Cicatiello L, Dauvois
S, Parker MG, Truss M, Beato M, Sica V, Bresciani F and Weisz A:
17beta-Estradiol induces cyclin D1 gene transcription,
p36D1-p34cdk4 complex activation and p105Rb phosphorylation during
mitogenic stimulation of G(1)-arrested human breast cancer cells.
Oncogene. 12:2315–2324. 1996.
|
|
40.
|
Cicatiello L, Addeo R, Sasso A, Altucci L,
Petrizzi VB, Borgo R, Cancemi M, Caporali S, Caristi S, Scafoglio
C, Teti D, Bresciani F, Perillo B and Weisz A: Estrogens and
progesterone promote persistent CCND1 gene activation during G1 by
inducing transcriptional derepression via c-Jun/c-Fos/estrogen
receptor (progesterone receptor) complex assembly to a distal
regulatory element and recruitment of cyclin D1 to its own gene
promoter. Mol Cell Biol. 24:7260–7274. 2004.
|
|
41.
|
Velasco-Velazquez MA, Li Z, Casimiro M,
Loro E, Homsi N and Pestell RG: Examining the role of cyclin D1 in
breast cancer. Future Oncol. 7:753–765. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Smith LM, Wise SC, Hendricks DT, Sabichi
AL, Bos T, Reddy P, Brown PH and Birrer MJ: cJun overexpression in
MCF-7 breast cancer cells produces a tumorigenic, invasive and
hormone resistant phenotype. Oncogene. 18:6063–6070. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Liu Y, Lu C, Shen Q, Munoz-Medellin D, Kim
H and Brown PH: AP-1 blockade in breast cancer cells causes cell
cycle arrest by suppressing G1 cyclin expression and reducing
cyclin-dependent kinase activity. Oncogene. 23:8238–8246. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Vleugel MM, Greijer AE, Bos R, van der
Wall E and van Diest PJ: c-Jun activation is associated with
proliferation and angiogenesis in invasive breast cancer. Hum
Pathol. 37:668–674. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Jiao X, Katiyar S, Willmarth NE, Liu M, Ma
X, Flomenberg N, Lisanti MP and Pestell RG: c-Jun induces mammary
epithelial cellular invasion and breast cancer stem cell expansion.
J Biol Chem. 285:8218–8226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Shin S and Janknecht R: Activation of
androgen receptor by histone demethylases JMJD2A and JMJD2D.
Biochem Biophys Res Commun. 359:742–746. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Pienta KJ and Bradley D: Mechanisms
underlying the development of androgen-independent prostate cancer.
Clin Cancer Res. 12:1665–1671. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Attard G, Cooper CS and de Bono JS:
Steroid hormone receptors in prostate cancer: a hard habit to
break? Cancer Cell. 16:458–462. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Kim TD, Shin S, Berry WL, Oh S and
Janknecht R: The JMJD2A demethylase regulates apoptosis and
proliferation in colon cancer cells. J Cell Biochem. 113:1368–1376.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Gray SG, Iglesias AH, Lizcano F,
Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW,
Kokkotou E and Dangond F: Functional characterization of JMJD2A, a
histone deacetylase- and retinoblastoma-binding protein. J Biol
Chem. 280:28507–28518. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Zhang D, Yoon HG and Wong J: JMJD2A is a
novel N-CoR-interacting protein and is involved in repression of
the human transcription factor achaete scute-like homologue 2
(ASCL2/ Hash2). Mol Cell Biol. 25:6404–6414. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Wagner EJ and Carpenter PB: Understanding
the language of Lys36 methylation at histone H3. Nat Rev Mol Cell
Biol. 13:115–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Parseghian MH, Newcomb RL, Winokur ST and
Hamkalo BA: The distribution of somatic H1 subtypes is non-random
on active vs. inactive chromatin: distribution in human fetal
fibroblasts. Chromosome Res. 8:405–424. 2000. View Article : Google Scholar
|
|
54.
|
Daujat S, Zeissler U, Waldmann T, Happel N
and Schneider R: HP1 binds specifically to Lys26-methylated histone
H1.4, whereas simultaneous Ser27 phosphorylation blocks HP1
binding. J Biol Chem. 280:38090–38095. 2005. View Article : Google Scholar : PubMed/NCBI
|
